Details for 2013002792

Up to date per 05.04.2026

Actions

Title / Product Name

Verwendung von zelldurchlässigen Peptidhemmern des JNK-Signaltransduktionsweges zur Behandlung verschiedener Autoimmunerkrankungen

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013002792

EP Publication Number

2650007

E-Number

727394

Language

PCT Number

Publication Date

16.10.2013 A

20.05.2015 B1

Registration Date

20.05.2015

AT Publication Date

15.06.2015

Application Date

02.06.2009

Registration Number

Priorities

30.05.2008

PCT/EP2008/004341

IPC

A61K 38/01 20060101AFI20140523BHEP

Maximum Duration of Protection

02.06.2029

Owner

Xigen Inflammation Ltd.Arch. Makariou III 195 Neocleous House 3030 LimassolCY

Representative

Mag. Dr. P. N. Torggler, Dipl.Ing. Dr. St. Hofinger, Mag. Dr. M. Gangl, MMag. Dr. C. Maschler INNSBRUCK ( T)

Inventor

Bonny, ChristopheEn Vernaules 1580 AvenchesCH